Klingenstein Paul H Insider Trades

Insider Trading History

Track insider trading activity for Klingenstein Paul H. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Clovis Oncology
Clovis Oncology CLVS
Director
Holding Value $3.43k 42,223 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$252k 42,223 shares
$5.97
$0.08
Clovis Oncology
Clovis Oncology CLVS
Director
Holding Value $3.26k 40,138 shares
Last Trade
Jun 04, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$260k 40,138 shares
$6.48
$0.08
Clovis Oncology
Clovis Oncology CLVS
Director
Holding Value $0 0 shares
Last Trade
Jul 29, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$277k 25,862 shares
$10.70
$0.08
Clovis Oncology
Clovis Oncology CLVS
Director
Holding Value $4.82k 59,327 shares
Last Trade
Jul 29, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$277k 25,862 shares
$10.70
$0.08
Clovis Oncology
Clovis Oncology CLVS
Director
Holding Value $2.35k 28,882 shares
Last Trade
Jun 06, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$423k 28,882 shares
$14.66
$0.08
Clovis Oncology
Clovis Oncology CLVS
Director
Holding Value $1.2k 14,770 shares
Last Trade
Oct 11, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$412k 14,770 shares
$27.92
$0.08
Clovis Oncology
Clovis Oncology CLVS
Director
Holding Value $812 10,000 shares
Last Trade
Jun 08, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$596k 10,000 shares
$59.56
$0.08
Clovis Oncology
Clovis Oncology CLVS
Director
Holding Value $812 10,000 shares
Last Trade
Jun 09, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$152k 10,000 shares
$15.23
$0.08
Clovis Oncology
Clovis Oncology CLVS
Director
Holding Value $812 10,000 shares
Last Trade
Jun 11, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$872k 10,000 shares
$87.15
$0.08
Clovis Oncology
Clovis Oncology CLVS
Director
Holding Value $1.01k 12,414 shares
Last Trade
Jun 12, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$553k 12,414 shares
$44.52
$0.08
Histogen
Histogen HSTO
Director
Holding Value $444 22,203 shares
Last Trade
Feb 19, 2014 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$3.46M 30,216 shares
$114.40
$0.02
Histogen
Histogen HSTO
Director
Holding Value $18.9k 943,355 shares
Last Trade
Feb 19, 2014 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$147M 1,283,589 shares
$114.40
$0.02
Histogen
Histogen HSTO
Director
Holding Value $0 0 shares
Last Trade
Feb 19, 2014 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$4.19M 36,634 shares
$114.40
$0.02
Histogen
Histogen HSTO
Director
Holding Value $406 20,322 shares
Last Trade
Feb 19, 2014 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$2.32M 20,322 shares
$114.40
$0.02
Histogen
Histogen HSTO
Director
Holding Value $733 36,634 shares
Last Trade
Feb 19, 2014 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$4.19M 36,634 shares
$114.40
$0.02
Histogen
Histogen HSTO
Director
Holding Value $175 8,731 shares
Last Trade
Feb 19, 2014 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$999k 8,731 shares
$114.40
$0.02
Conatus Pharmaceuticals
Conatus Pharmaceuticals CNAT
Director
Holding Value $0 0 shares
Last Trade
Jul 30, 2013 Sale (In The Money)Reported as In The Money on SEC Form 4.
No data
No data
$0.00
Conatus Pharmaceuticals
Conatus Pharmaceuticals CNAT
Director
Holding Value $0 49,712 shares
Last Trade
Jul 30, 2013 Purchase (In The Money)Reported as In The Money on SEC Form 4.
No data
No data
$0.00
Conatus Pharmaceuticals
Conatus Pharmaceuticals CNAT
Director
Holding Value $0 49,949 shares
Last Trade
Jul 30, 2013 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.00
Conatus Pharmaceuticals
Conatus Pharmaceuticals CNAT
Director
Holding Value $0 30,000 shares
Last Trade
Jul 30, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up